Uploaded October 2026 | Updated November 2026, 2 days ago
What does “precision medicine” mean in cancer care—and how do researchers match treatment to a person’s individual tumor? In this video, Bayer shares how its oncology strategy prioritizes patient needs, scientific innovation, and progress across both common and rare tumor types.
You’ll hear how Bayer is responding to the evolving global oncology landscape by:
- Putting a patient-centered approach at the core of oncology R&D
- Building on existing therapies while advancing new treatment options
- Collaborating with leading research, pharmaceutical, advocacy, and academic partners
- Growing a differentiated oncology portfolio through internal and external innovation
- Focusing on areas of high unmet need, including prostate cancer and rarer tumor types
The video also highlights the shift toward treating cancers based on the genomic alterations driving tumor growth—not only where the cancer is located—supporting the goal of delivering precision oncology.
What does “precision medicine” mean in cancer care—and how do researchers match treatment to a person’s individual tumor? In this video, Bayer shares how its oncology strategy prioritizes patient needs, scientific innovation, and progress across both common and rare tumor types.
You’ll hear how Bayer is responding to the evolving global oncology landscape by:
- Putting a patient-centered approach at the core of oncology R&D
- Building on existing therapies while advancing new treatment options
- Collaborating with leading research, pharmaceutical, advocacy, and academic partners
- Growing a differentiated oncology portfolio through internal and external innovation
- Focusing on areas of high unmet need, including prostate cancer and rarer tumor types
The video also highlights the shift toward treating cancers based on the genomic alterations driving tumor growth—not only where the cancer is located—supporting the goal of delivering precision oncology.










